Dr. David E. Weinstein

David is a neurologist and neuroscientist and an internationally recognized expertin the areas of Multiple Sclerosis, brain tumor research, and spinal cord and nerveinjury andregeneration. Formerly served as CEO of GliaMed, Inc., the CMO and CSO of both RiverTown Therapeutics, Inc and InteKrin Therapeutics, Inc. Beforemoving to the biopharmaceutical sector, he was a Professor in the Departments of Neuroscience, Neurology, Pathology and the Comprehensive Cancer Center at the Albert Einstein College of Medicine, in New York.

Dr. Weinstein has served as aconsultant to the NIH and the World Health Organization and is an external advisorand consultant for numerous scientific research organizations as well as VC firms. In addition to his MD and PhD degrees from Columbia Uni. NY, David also holds an MS in Pharmacology from NY University College of Medicine. He is the inventor onseveral patents in the areas of tissue regeneration, neurology, neuropathology andviral diagnostics.